Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy

Abstract

Chronic lymphocytic leukemia (CLL) is an incurable lymphoproliferative disorder with a heterogeneous genetic and clinical course. Two kinase inhibitors, ibrutinib and idelalisib, have demonstrated achievement of complete and durable remissions in relapse/refractory genetically unselected CLL patients. We present a case of relapsed CLL with extensive disease… (More)
DOI: 10.1155/2017/3869020

Topics

1 Figure or Table

Cite this paper

@inproceedings{VelascoRodrguez2017ProstaticLikeSI, title={Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy}, author={Diego Velasco-Rodr{\'i}guez and Miguel Piris-Villaespesa and Carmen Soteras and Ana P{\'e}rez Vall{\'e}s and Jos{\'e} Antonio Garc{\'i}a-Marco and Jos{\'e} Antonio Garc{\'i}a-Vela}, booktitle={Case reports in hematology}, year={2017} }